Vesigen Therapeutics is Drug Delivery in United States that focus on patented technology business. Founded in 2019. They cover business area such as developer, therapeutic product, target intracellular drug delivery, next-generation therapeutic, armm, payload, RNAs, protein, editing complex, target cell, druggable target, new therapy, address, medical need.
2019
( 5 years old in 2024 )
Patented Technology
-
790 Memorial Drive
Suite 103
Cambridge, MA 02139
United States
Private
developertherapeutic producttarget intracellular drug deliverynext-generation therapeuticarmmpayloadRNAsproteinediting complextarget celldruggable targetnew therapyaddressmedical need
* We use standard office opening hours in near Vesigen Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vesigen Therapeutics is Drug Delivery business from United States that founded in 2019 (5 years old in 2024), Vesigen Therapeutics business is focusing on Patented Technology.
Vesigen Therapeutics headquarter office and corporate office address is located in 790 Memorial Drive Suite 103 Cambridge, MA 02139 United States.
Vesigen Therapeutics was founded in United States.
In 2024, Vesigen Therapeutics is currently focus on patented technology sector.
Above is snippet of Google Trends for "patented technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vesigen Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
